Mechanism of action of H2-antagonists on histamine-or dimaprit-stimulated H2-receptors of spontaneously beating guinea-pig atrium
- 1 August 1990
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 31 (1-2) , 23-35
- https://doi.org/10.1007/bf02003217
Abstract
Cimetidine, ranitidine and famotidine are antagonists of the histamine H2-receptors on the spontaneously beating right atrium of the guinea pig. When analyzed by the classical Schild method theirpA 2-values are respectively: 6.3, 6.8 and 7.7 with dimaprit as agonist and 5.8, 6.5 and 7.7 with histamine as agonist. Radiolignad-displacement studies with [3H]-tiotidine as radioligand resulted inpK d values for cimetidine, ranitidine and famotidine of 6.3; 6.9 and 8.2 respectively. In dimaprit-stimulated atria all antagonists added at concentrations above theirK d values depressed the maximal increase in frequency. In the presence of histamine this effect was much less pronounced and only visible at concentrations of ranitidine and famotidine around 10 ·K d. The rightward shift of the curves as well as the decrease inE max are reversible but the dissociation constants of the antagonists are small (less than 10−3 s−1). The spontaneously beating right atrium showed receptor reserve for histamine and virtually no receptor reserve for dimaprit. The results have been interpreted in a model in which H2-antagonists act mainly by competing with the agonist for the histamine receptor site but have in addition a distinct affinity for a secondary site on the receptor. Occupation of this site by the antagonist prevents building up of the stimulus elicited by the agonist and thus decreases theE max. In systems with receptor reserve (histamine) the effect of antagonist binding to the secondary binding site is seen only at high concentration of antagonist while in absence of receptor reserve (dimaprit) the depression ofE max is directly visible. Simulations of the model show that the affinity of this secondary binding site is 50- (famotidine) to 100-(cimetidine and ranitidine) fold lower than for the agonist binding site.This publication has 29 references indexed in Scilit:
- Relation between pharmacological response and receptor binding with histamine blocking drugs. Irreversible antagonism of three analogues of mifentidine on right atrium and cerebral cortex of the guinea-pigInflammation Research, 1987
- Inhibitory effect of famotidine on cat gastric secretionInflammation Research, 1986
- Pharmacology of the novel H2 antagonist famotidine: In vitro studiesInflammation Research, 1986
- H2-receptor antagonist and gastric acid antisecretory properties of Wy-45,662Inflammation Research, 1986
- Pharmacological profile of mifentidine: A novel H2-receptor antagonistInflammation Research, 1985
- The use of anin vitro binding assay to predict histamine H2-antagonist activityInflammation Research, 1985
- Studies on the H2-receptor antagonism of MK-208 in isolated rabbit gastric glandsEuropean Journal of Pharmacology, 1984
- Specific binding of 3H-tiotidine to histamine H2 receptors in guinea pig cerebral cortexNature, 1983
- Dimaprit-[S-[3-(N,N-dimethylamino)propyl]isothiourea] —A highly specific histamine H2-receptor agonist. Part 1. PharmacologyInflammation Research, 1977
- Definition and Antagonism of Histamine H2-receptorsNature, 1972